Klotho, vitamin D and homocysteine levels during acute episode and remission periods in schizophrenia patients

References

• Kahn RS, Sommer IE, Murray RM. Schizophrenia. Nat Rev Dis Primers. 2015;1:15067.
   PubMed Web of Science ®Google Scholar
• Rund BR. Is schizophrenia a neurodegenerative disorder? Nord J Psychiatry. 2009;63:196–201.
   PubMed Web of Science ®Google Scholar
• Dubal DB, Yokoyama JS, Zhu L, et al. Life extension factor klotho enhances cognition. Cell Rep. 2014;7:1065–1076.
   PubMed Web of Science ®Google Scholar
• Imura A, Iwano A, Tohyama O, et al. Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane . FEBS Lett. 2004;565:143–147.
   PubMed Web of Science ®Google Scholar
• Quintero-Platt G, González-Reimers E, Rodríguez-Gaspar M, et al. Alpha Klotho and fibroblast growth factor-23 among alcoholics. Alcohol Alcohol. 2017;52:542–549.
   PubMed Web of Science ®Google Scholar
• Prystupa A, Dąbrowska A, Sak JJ, et al. Concentrations of fetuin-A, osteoprotegerin and α-Klotho in patients with alcoholic liver cirrhosis. Exp Ther Med. 2016;12:3464–3470.
   PubMed Web of Science ®Google Scholar
• Leon J, Moreno AJ, Garay BI, et al. Peripheral elevation of a klotho fragment enhances brain function and resilience in young, aging, and α-synuclein transgenic mice. Cell Rep. 2017;20:1360–1371.
   PubMed Web of Science ®Google Scholar
• Bowie CR, et al. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis. Bipolar Disord. 2018;20(7):604–613.
   PubMed Web of Science ®Google Scholar
• Joseph J, Kremen WS, Glatt SJ, et al. Assessment of Lifespan Functioning Attainment (ALFA) scale: a quantitative interview for self-reported current and functional decline in schizophrenia. J Psychiatr Res. 2015;65:102–107.
   PubMed Web of Science ®Google Scholar
• Aspell N, Lawlor B, O'Sullivan M. Is there a role for vitamin D in supporting cognitive function as we age? Proc Nutr Soc. 2018;77:124–134.
   PubMed Web of Science ®Google Scholar
• Shardell M, Semba RD, Kalyani RR, et al. Serum 25-hydroxyvitamin D, plasma Klotho, and lower-extremity physical performance among older adults: Findings from the InCHIANTI Study. Gerona. 2015;70:1156–1162.
   Web of Science ®Google Scholar
• Guo Y, Zhuang X-D, Xian W-B, et al. Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy. CNS Neurosci Ther. 2017;23:657–666.
   PubMed Web of Science ®Google Scholar
• de Jager CA. Critical levels of brain atrophy associated with homocysteine and cognitive decline. Neurobiol Aging. 2014;35:S35–S39.
   PubMed Web of Science ®Google Scholar
• Frankenburg FR. The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry. 2007;15:146–160.
   PubMed Web of Science ®Google Scholar
• Nishi A, Numata S, Tajima A, et al. Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia. Schizophr. Bull. 2014; 40: 1154–1163.
   Google Scholar
• Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: Comparing apples and oranges! Indian J Psychiatry. 2013;55:207–208.
   PubMed Web of Science ®Google Scholar
• Leucht S, Samara M, Heres S, et al. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull. 2014;40:314–326.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV axis I disorders-clinician version (SCID-CV) New York: State Psychiatric Institute, Biometrics Research; 1997.
   Google Scholar
• Çorapçıoglu A, Aydemir O, Yıldız M, et al. DSM-IV Eksen-I Bozuklukları İçin Yapılandırılmış Klinik Görüşme. Ankara (Turkey): Hekimler Yayın Birliği; 1999.
   Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261.
   PubMed Web of Science ®Google Scholar
• Kostakoğlu AE. Pozitif ve Negatif Sendrom Ölçeğinin (PANSS) Türkçe uyarlamasının geçerlilik ve güvenilirliği. Türk Psikoloji Dergisi. 1999;14:23–32.
   Web of Science ®Google Scholar
• Guy W. EC-DEU Assessment Manual for Psychopharmacology, Revised CGI Clinical Global Impressions. Rockville, Md: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976;76–339.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington (DC): American Psychiatry Association. 1994.
   Google Scholar
• Deary IJ, Harris SE, Fox HC, et al. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neurosci Lett. 2005;378:22–27.
   PubMed Web of Science ®Google Scholar
• Morar B, Badcock JC, Phillips M, et al. The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia. Schizophr Res. 2018;193:348–353.
   PubMed Web of Science ®Google Scholar
• Yokoyama JS, Marx G, Brown JA, et al. Systemic klotho is associated with KLOTHO variation and predicts intrinsic cortical connectivity in healthy human aging. Brain Imaging Behav. 2017;11:391–400.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu H, Liu J, et al. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma. PLoS One. 2013;8:e58413.
   PubMed Web of Science ®Google Scholar
• Carlborg A, Jokinen J, Nordström A-L, et al. Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis. Nord J Psychiatry. 2011;65:101–105.
   PubMed Web of Science ®Google Scholar
• Pedersen L, Pedersen SM, Brasen CL, et al. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. Clin Biochem. 2013;46:1079–1083.
   PubMed Web of Science ®Google Scholar
• Regland B, Johansson BV, Grenfeldt B, et al. Homocysteinemia is a common feature of schizophrenia. J Neural Transm Gen Sect. 1995;100:165–169.
   PubMed Web of Science ®Google Scholar
• Levine J, Stahl Z, Sela BA, et al. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry. 2002;159:1790–1792.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo R, Amoretti A, Baldini S, et al. Homocysteine levels in schizophrenia patients newly admitted to an acute psychiatric ward. Acta Neuropsychiatr. 2015;27:336–344.
   PubMed Web of Science ®Google Scholar
• Muntjewerff JW, Kahn RS, Blom HJ, et al. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:143–149.
   PubMed Web of Science ®Google Scholar
• Eren E, et al. Serum total homocystein, folate and vitamin B12 levels and their correlation with antipsychotic drug doses in adult male patients with chronic schizophrenia. Clin Lab. 2010;56:513–518.
   PubMed Web of Science ®Google Scholar
• Moustafa AA, Hewedi DH, Eissa AM, et al. Homocysteine levels in schizophrenia and affective disorders—focus on cognition. Front Behav Neurosci. 2014;8:343.
   PubMed Web of Science ®Google Scholar
• Shi J, Gershon ES, Liu C. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res. 2008;104:96–107.
   PubMed Web of Science ®Google Scholar
• Bouaziz N, Ayedi I, Sidhom O, et al. Plasma homocysteine in schizophrenia: determinants and clinical correlations in Tunisian patients free from antipsychotics. Psychiatry Res. 2010;179:24–29.
   PubMed Web of Science ®Google Scholar